<DOC>
	<DOCNO>NCT02222194</DOCNO>
	<brief_summary>In case PET CT base cN1 ( suspect ) NSCLC , ESTS guideline propose mediastinal stag echo-endoscopy OR mediastinoscopy . Recent data show sensitivity le 50 % echo-endoscopy detect N2 disease cN1 NSCLC patient , prevalence mediastinal nodal disease 24 % ( unpublished data Aster II ) .2 The investigator plan perform prospective multicentric observational study measure sensitivity mediastinal stag video-assisted mediastinoscopy ( VAM ) cN1 operable resectable ( suspect ) NSCLC patient .</brief_summary>
	<brief_title>The Value Surgical Mediastinal Staging Clinical N1 Lung Cancer</brief_title>
	<detailed_description>Few report literature evaluate final pathological stage distribution patient resectable operable non-small cell lung cancer ( NSCLC ) clinical stage cN1 . These retrospective series demonstrate patient compute tomography ( CT ) base cN1 often clinically occult mediastinal lymph node metastasis ( N2/3 disease ) . Hishida et al . report 30 % 143 patient cN1 diagnose N2/3 mediastinoscopy3 . Watanabe et al . report 37 % 168 patient cN1 diagnose N2/3 mediastinoscopy 4 . Adding FDG-positron emission tomography ( PET ) CT might enable detection N2/3 disease among cN1 patient , negative PET finding necessarily exclude N2/3 disease . Kim et al report 19,2 % 99 patient cN1 , cN2 rule PET-CT scan , find pathologic N2 disease pulmonary resection mediastinal lymph node dissection.5 In conclusion , 20-30 % patient cN1 node image , normal size FDG-negative mediastinal lymph node CT PET malignant involvement mediastinal node . The ACCP guideline state invasive preoperative mediastinal staging perform cN1 patient 6 . The updated ESTS guideline recommend mediastinal stag echo-endoscopic mediastinoscopy.1 Non-randomized trial suggest potential linear endosonography mediastinal stag 7-9 . However , patient cN1 disease form minority study . A recently perform prospective ASTER 2 trial ( N=100 ) show sensitivity echo-endoscopic mediastinal stag 38 % ( ITT analysis ) , prevalence mediastinal nodal disease 24 % ( unpublished data Aster 2 ) 2 . The conclusion make ASTER 2 negative endosonography must follow VAM . However , investigator consider double approach cost-effective set N2 prevalence &lt; 30 % . Therefore , seem reasonable perform VAM instead endosonography cN1 patient , one propose strategy recent ESTS guidelines.1 However , prospective study date assess sensitivity , NPV accuracy VAM well-defined group cN1 patient . Several publication demonstrate lobe-specific mediastinal nodal drainage upper versus lower lobe NSCLC . Shapiro et al conclude early lung cancer , include cN1 disease , lobe-specific mediastinal dissection warrant 10 . However , study patient positive subcarinal node , upper lobe tumour , negative superior mediastinal node positive N1 node . To investigator knowledge study focus mediastinal nodal dissemination pattern cN1 patient .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>( Suspected ) NSCLC Medical operable surgical resectable cT1 , cT2 select cT3 ( i.e . intraparenchymal tumour &gt; 7cm , T3 chest wall , T3 base additional nodule lobe primary tumour ) cN1 base CT PET 18 year old Informed Consent History mediastinoscopy No integrated FDG PET/CT available No videomediastinoscopy available EBUS/EUS mediastinal stag present N1 disease cN2 : mediastinal node enlarge CT Pet positive invasion mediastinal pleura invasion phrenic nerve invasion parietal pericardium tumour main bronchus less 2cm form main carina cT4 cM1 former therapy lung cancer ( chemotherapy , radiotherapy , surgery ) technical contraindication videomediastinoscopy ( eg extreme kyphosis , cutaneous tracheostomy , extreme goiter ) pregnancy inability consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Surgery</keyword>
	<keyword>Videomediastinoscopy</keyword>
</DOC>